Company news

Novamind Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Novamind to Present at Benzinga Healthcare Conference

September 29, 2021

Novamind Announces DTC Eligibility for its Common Shares

September 24, 2021

Novamind to Present at Benzinga Healthcare Conference

September 23, 2021

Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF

September 20, 2021

Novamind to Present at Life Sciences Investor Forum

September 14, 2021

Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial

September 13, 2021

Novamind Uplists to OTCQB Venture Market

September 9, 2021

Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference

September 8, 2021

Novamind Divests Non-Core Retreat Investment

August 11, 2021

Novamind Strengthens Mental Health Expertise, Adds Communications Leader

August 6, 2021

Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions

July 29, 2021

Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States

July 21, 2021

Novamind Selected as Research Site for Bionomics' PTSD Clinical Trial

July 8, 2021

Novamind Launches Psychedelic Therapy Frontiers Podcast

June 30, 2021

Novamind Welcomes Dr. Paul Thielking as Chief Scientific Officer

June 23, 2021

Novamind Announces US$1,000,000 Strategic Investment in Stealth Mode Drug Development Company

June 17, 2021

Novamind to Present at the H.C. Wainwright Psychedelics Conference on June 17, 2021

June 15, 2021

Novamind Launches Psychedelic Therapy Protocol for Frontline Healthcare Workers

June 10, 2021

Novamind Reports Fiscal Q3 Financial Results and Operating Highlights

June 1, 2021

Novamind Opens Client Care Center to Support High Demand for Treatments

May 18, 2021

Novamind Doubles in Size, Adds Four New Psychedelic Mental Health Clinics

May 4, 2021

Novamind Collaborates with Center for Change

April 21, 2021

Novamind Announces Participation at the Planet MicroCap Showcase on April 20 - 22, 2021

April 20, 2021

Novamind to Present at the Planet MicroCap Virtual Event on April 22, 2021

April 19, 2021

Novamind Increases Strategic Investment in Bionomics

April 13, 2021

Novamind to Present at Benzinga Biotech Conference

March 24, 2021

Novamind to Present at Benzinga Biotech Conference

March 22, 2021

Novamind Partners with Merck for New Treatment-Resistant Depression Trial

March 18, 2021

Novamind Expands Leadership Team, Accelerating M&A

March 3, 2021

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

March 1, 2021

Novamind to Present at Benzinga Conference

February 24, 2021

Novamind to Present at Benzinga Conference

February 23, 2021

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

February 22, 2021

Novamind Announces Symbol Change on OTC Market To "NVMDF"

February 19, 2021

Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial

February 11, 2021

Novamind to Present at Canaccord Genuity Conference: "New Paradigms & Treatment Approaches in Mental Health"

January 29, 2021

Novamind Reaches Major Milestones for Ketamine and Spravato(TM) Treatments

January 28, 2021

Novamind Announces Marketing Services Agreements

January 26, 2021

Novamind to Present at Inaugural KCSA Psychedelics Investor Conference

January 25, 2021

Former LifeLabs COO Joins Novamind Leadership Team

January 19, 2021

Novamind Expands Psychedelic Medicine Access in Utah

January 13, 2021

Novamind Appoints Chuck Rifici to its Board of Directors

January 8, 2021

← Newer news releases

Decks